Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial

The Dominican Republic, historically non-endemic for cholera, is experiencing an ongoing cholera epidemic. We assessed the safety and immunogenicity of two doses of the killed bivalent (O1 and O139) whole-cell oral cholera vaccine (OCV) on day (D)0 and D14 in healthy participants aged ≥1 year. Immed...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordero De Los Santos, Lina, Feris-Iglesias, Jesús, Aloysia D'Cor, Naveena, Midde, Venkata Jayanth, Patnaik, Badri Narayan, Thollot, Yaël, Rasuli, Anvar, Desauziers, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037475/
https://www.ncbi.nlm.nih.gov/pubmed/29470934
http://dx.doi.org/10.1080/21645515.2018.1430540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037475/
https://www.ncbi.nlm.nih.gov/pubmed/29470934
http://dx.doi.org/10.1080/21645515.2018.1430540

Ejemplares similares